Amarin Corp Plc (AMRN)

[shadolane]

With the pps at a little over $3 any BO price would be rather anemic.

So I am of the opinion that management isn't pursuing that angle. Unless of course Denner pushes it. Even then the buyout price would remain anemic.

While we have no way of knowing I am guessing there is no BP who is interested. They have witnessed the same things we have with regard to MO, insurance coverage, litigations, and the entry of generics. Why would they want to step into a bucket of dog DU DU?

They may even be laughing at this circus.

After passing the FDA requirements this whole saga has become everything but the science.

We all may very well have to sell at break even or a loss to escape this nightmare.